Biogen Message Board - Msg: 5590885

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biogen

BIIB 175.32

+4.2%

Nov 21 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Hong-Lee Yu who wrote (710)	8/26/1998 9:00:00 AM
From: Harold Engstrom	Read Replies (1) of 1686

"new IMS Health data showing new U.S. weekly prescriptions of Avonex hit 1,147 in the week ending August 7, about 10 percent higher than any previous week. In addition, he said data released by the market research firm showed total U.S. prescriptions written for Avonex that week were at an all-time high of 4,572." I read this to say 1147 prescriptions for people who did not have prescriptions for Avonex before. And, that there were 4,572 total prescriptions written for Avonex that week. Also, IMS picks up about 85% of the US channels, so presumeably the numbers may be even better. How do you interpret the above?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next